Re-evaluating Stroke Thrombectomy Extended Window Outcomes

Acute ischemic stroke secondary to large vessel occlusion remains a leading cause of long-term neurodisability worldwide. While endovascular therapy represents the standard of care for early-presenting anterior circulation occlusions, evaluating patients for stroke thrombectomy extended window intervention presents unique physiological and operational challenges. Historically, procedural benefits were thought to decline steeply as hours elapsed from symptom onset, reflecting the traditional "time is brain" paradigm established in early-window trials. However, advanced neuroimaging modalities—including computed tomography perfusion and magnetic resonance imaging diffusion-perfusion mismatch—have revolutionized patient selection beyond six hours. By identifying salvageable ischemic penumbra despite prolonged symptoms, clinicians can extend therapeutic eligibility up to 24 hours. Despite diagnostic advancements, uncertainty has persisted regarding how specific time metrics, such as onset-to-presentation versus door-to-reperfusion intervals, influence clinical outcomes in late-presenting cohorts. Understanding whether treatment efficacy wanes or remains durable across six to twenty-four hours is vital for emergency stroke networks, neurointerventionalists, and critical care specialists. Recent meta-analytic data pooling individual patient data from landmark randomized clinical trials offer key insights into these time dynamics, providing clearer guidance for acute stroke protocols.

Individual Patient-Data Meta-Analysis Methodology

To clarify the impact of time parameters in late-presenting acute ischemic stroke, investigators pooled individual patient-level data from six major randomized controlled trials evaluating endovascular thrombectomy in the six-to-twenty-four-hour post-onset window. The meta-analysis encompassed 505 participants with large vessel occlusions who were randomized to receive either endovascular thrombectomy alongside best medical management or best medical management alone. Overall, 266 patients received endovascular therapy, while 239 control participants received medical therapy alone. The study cohort presented with a median age of 70 years and a high baseline neurological deficit, reflected by a median National Institutes of Health Stroke Scale score of 16. Women comprised 51.3% of the total study population, and advanced neuroimaging criteria guided treatment selection in 86.5% of cases. The primary endpoint was functional disability at 90 days, assessed quantitatively using the modified Rankin Scale across its full spectrum. Secondary outcomes included functional independence, defined as a modified Rankin Scale score of 0 to 2, 90-day mortality, and symptomatic intracranial hemorrhage. This pooled dataset provided sufficient statistical power to dissect the complex relationship between various treatment time intervals and post-stroke recovery outcomes.

Onset-to-Randomization Dynamics and the Late-Window Paradox

The study revealed striking differences in outcome patterns between thrombectomy and medical control cohorts relative to onset-to-randomization timing. Among patients undergoing mechanical thrombectomy, longer intervals between symptom onset and randomization were not associated with worsening disability or reduced rates of functional independence. Adjusted odds ratios per 60-minute delay remained nonsignificant for both disability outcomes and functional independence. Conversely, control patients receiving medical therapy alone experienced progressive neurological decline as onset-to-randomization intervals lengthened. Longer delays in the control arm significantly decreased the odds of achieving functional independence and increased overall disability scores. Consequently, the relative treatment benefit of endovascular thrombectomy appeared to expand at later time points rather than contract, as demonstrated by significant interaction statistics. Rather than indicating true temporal insensitivity, this phenomenon—often termed the late-window paradox—reflects the biological characteristics of slow progressors. Patients who maintain eligible imaging profiles late into the extended window possess robust collateral circulation that sustains penumbral tissue over extended durations. Thus, imaging selection effectively filters out rapid progressors, enriching late-presenting cohorts with individuals who retain substantial salvageable brain tissue and gain marked therapeutic benefit from recanalization.

The Critical Risk of In-Hospital and Procedural Delays

While pre-hospital delay did not diminish the absolute efficacy of thrombectomy in image-selected patients, in-hospital procedural timing demonstrated a powerful effect on patient recovery. Analysis of acute procedural metrics revealed that longer intervals from randomization to arterial reperfusion were strongly correlated with worse 90-day clinical outcomes. For every hour of delay between randomization and successful reperfusion, the adjusted odds ratio for achieving lower disability fell substantially. Similarly, extended randomization-to-reperfusion times significantly reduced the likelihood of achieving functional independence. Interestingly, onset-to-puncture and onset-to-reperfusion intervals showed no direct statistical association with outcomes in the thrombectomy cohort when evaluated without separating in-hospital workflow metrics. This critical distinction underscores that once a patient enters the hospital system, intra-procedural timing becomes paramount. Advanced imaging selection essentially resets the clinical clock upon patient arrival, but it does not grant immunity against subsequent delays. Sluggish door-to-imaging, door-to-puncture, or puncture-to-recanalization times directly compromise ischemic tissue that may already be operating on limited collateral supply. Therefore, streamlined in-hospital emergency stroke pathways remain mandatory regardless of presentation time.

Mechanistic Physiology and Biological Selection of Slow Progressors

Understanding the pathophysiological mechanisms governing extended-window thrombectomy requires evaluating cerebral collateral hemodynamics. Infarct core growth rate varies widely among stroke patients depending on arterial collateral score, systemic blood pressure, microvascular resistance, and ischemic preconditioning. Rapid progressors experience swift core expansion and irreversible tissue infarction within hours, excluding them from late-window trials based on advanced imaging criteria. In contrast, slow progressors maintain viable, hypoperfused penumbra surrounding a small core for many hours or even days. Advanced perfusion neuroimaging identifies these physiological profiles by mapping core-penumbra mismatch or clinical-core mismatch. When clinicians apply strict imaging selection, they effectively isolate individuals whose brain tissue tolerates ischemia for prolonged durations. This biological filtering explains why pre-hospital time metrics appear disconnected from functional outcomes in the intervention arm. However, this physiological resilience is not infinite. Delaying intra-procedural recanalization once imaging is complete allows microvascular thrombosis, reperfusion injury, and collateral failure to exhaust the remaining penumbra. Thus, advanced neuroimaging acts as a precise gatekeeper, ensuring that intervention is directed strictly to patients who possess viable tissue while reinforcing the necessity of rapid arterial recanalization once candidates are identified.

Translating Evidence into Emergency Stroke Systems and Care Guidelines

These meta-analytic findings carry direct operational implications for acute stroke care networks and emergency referral pathways. Emergency medical services, triage physicians, and stroke teams should not deny transfer or advanced imaging evaluation to patients presenting in the 6-to-24-hour window solely based on prolonged time elapsed since last known well. Systems of care must establish streamlined protocols for rapid automated perfusion imaging or multiphasic CT angiography to screen late arrivals promptly. Once imaging confirms an eligible tissue mismatch, hospital workflows must transition into hyper-acute emergency modes. Standardized protocols targeting door-to-puncture times under 60 minutes and puncture-to-recanalization times under 30 minutes are as essential in the extended window as they are in the early window. Interdisciplinary coordination between emergency physicians, neuroradiologists, neurointerventionalists, and neuro-intensive care specialists must focus on removing internal systemic bottlenecks. Furthermore, ongoing quality improvement initiatives should track randomization-to-reperfusion and door-to-reperfusion metrics as core performance benchmarks. By combining physiological imaging selection with swift procedural execution, stroke centers can maximize functional recovery, minimize long-term disability, and optimize clinical outcomes for late-presenting large vessel occlusion patients.

Frequently Asked Questions

Why does thrombectomy efficacy remain stable across late time windows?

Thrombectomy efficacy remains stable in late time windows because advanced neuroimaging selectively identifies slow progressors who retain viable penumbral tissue due to robust collateral circulation. By excluding rapid progressors with completed infarcts, physiological selection effectively resets the treatment clock for eligible patients presenting between 6 and 24 hours.

How do in-hospital delays impact outcomes in extended-window thrombectomy?

In-hospital delays significantly worsen functional recovery in extended-window patients. Longer intervals between randomization and successful arterial reperfusion correlate strongly with higher 90-day disability and reduced functional independence. Once an eligible tissue mismatch is confirmed on neuroimaging, rapid procedural execution remains crucial to salvage ischemic brain tissue.

What selection criteria are recommended for late-presenting stroke patients?

Clinical guidelines recommend using advanced neuroimaging criteria, such as automated CT perfusion or MRI diffusion-perfusion mismatch, to identify eligible candidates presenting within 6 to 24 hours. These modalities evaluate core-penumbra mismatch and clinical-deficit severity, ensuring thrombectomy is offered to individuals with significant salvageable brain tissue despite delayed presentation.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Nogueira RG et al. Time to Treatment in Stroke Thrombectomy and Outcomes in the Extended Time Window: A Meta-Analysis. Neurology. 2026 Aug 11. doi: 10.1212/WNL.0000000000218113. PMID: 42475646.


2. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11-21.


3. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Ischemic Stroke 6 to 16 Hours after Loss of Well-Being. N Engl J Med. 2018;378(8):708-718.